m+Medelevator.RU
← Поиск публикаций
Macromolecular bioscience · 2025

Polydopamine-Antibiotic Composite Coating for Antibiofilm Applications.

СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Kropp Gillian A, Karp Hannah Q, Rao Jayasimha, Muller Henriette Suzanne, Sriranganathan Nammalwar, Nowak Elizabeth S, Schulz Michael D

Аннотация

Urinary catheterization is a common procedure, affecting 15%-25% of hospitalized patients. This procedure, however, often results in bacterial infections, primarily caused by biofilm-forming Gram-negative bacteria that adhere to the catheter surface. To address this challenge, we developed a polymer-based antimicrobial coating using polydopamine (PD) embedded with gentamicin (Gent). We evaluated the antibiofilm efficacy of this coating (PD-Gent) using a biofilm-forming isolate of Pseudomonas aeruginosa (PAO1) as P. aeruginosa is commonly implicated in catheter-related infections. We observed that the PD-Gent coating significantly reduced biofilm formed by PAO1 compared to the uncoated control. Importantly, the coating maintained its antibiofilm activity across diverse substrates, including polystyrene, poly(vinyl chloride), and silicone. The approach was further extended to incorporate other antibiotics (tobramycin, amikacin), demonstrating adaptability to multiple antimicrobial agents. Finally, artificial urine inoculated with PAO1 was deployed through PD-Gent-coated silicone Foley catheters under continuous flow for 24 h. Despite this continuous introduction of PAO1, the coated catheters inhibited biofilm formation by three-fold compared to the uncoated control catheters. These findings underscore the promise of PD-Gent as a robust, versatile coating with strong potential to significantly reduce the incidence of catheter-associated infections in clinical settings.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты